Revisions of 'Dementia'

• Revision 9 - created 5 months ago by Arlene Campos ◉ - view changeset
  Date: 2024-06-27 06:50:42 UTC Disclosures:

  At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.

  View Arlene Campos's current disclosures Reviewed by: Joachim Feger
• Revision 8 - created 7 months ago by Rohit Sharma ◉ - view changeset
  Date: 2024-05-19 22:58:51 UTC Disclosures:

  At the time the revision was created Rohit Sharma had no financial relationships to ineligible companies to disclose.

  View Rohit Sharma's current disclosures Reviewed by: Joachim Feger
• Revision 7 - created about 1 year ago by Patrick O'Shea ◉ - view changeset
  Date: 2023-10-20 08:47:15 UTC Disclosures:

  At the time the revision was created Patrick O'Shea had no financial relationships to ineligible companies to disclose.

  View Patrick O'Shea's current disclosures Reviewed by: Simran Sampath Kumar
• Revision 6 - created about 1 year ago by Patrick O'Shea ◉ - view changeset
  Date: 2023-10-09 02:24:51 UTC Disclosures:

  At the time the revision was created Patrick O'Shea had no financial relationships to ineligible companies to disclose.

  View Patrick O'Shea's current disclosures Reviewed by: Rohit Sharma
• Revision 5 - created about 1 year ago by Henry Knipe ◉ - view changeset
  Date: 2023-10-06 01:01:42 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Joachim Feger
• Revision 4 - created about 1 year ago by Frank Gaillard ◉ ◈ - view changeset
  Date: 2023-10-06 00:13:24 UTC Disclosures:

  At the time the revision was created Frank Gaillard had the following disclosures:

  • Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Frank Gaillard's current disclosures Reviewed by: Joachim Feger
• Revision 3 - created about 1 year ago by Henry Knipe ◉ - view changeset
  Date: 2023-10-05 21:12:06 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Joachim Feger
• Revision 2 - created about 1 year ago by Frank Gaillard ◉ ◈ - view changeset
  Date: 2023-10-01 22:55:03 UTC Disclosures:

  At the time the revision was created Frank Gaillard had the following disclosures:

  • Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Frank Gaillard's current disclosures Reviewed by: Rohit Sharma
• Revision 1 - created about 1 year ago by Patrick O'Shea ◉ - view changeset
  Date: 2023-10-01 08:02:51 UTC Disclosures:

  At the time the revision was created Patrick O'Shea had no financial relationships to ineligible companies to disclose.

  View Patrick O'Shea's current disclosures Reviewed by: Rohit Sharma

Unfortunately some older revisions may not be able to be viewed or restored.